Multiple Myeloma
Estrogen derivative defeats drug resistant cells in bone marrow cancer
Published in Cancer Weekly, October 1st, 2002
The growth of multiple myeloma, a bone marrow cancer that mostly affects men, depends on angiogenesis and oncogenic activity. 2-Methoxyestradiol (2ME2) regulates cancer growth influences such as apoptosis and angiogenesis.
Researchers at the Dana-Farber Cancer Institute at Harvard Medical School in Boston, Massachusetts think 2ME2 may extend survival in multiple myeloma (MM) patients by enabling cancer cells to overcome resistance to standard therapies.
The Harvard team evaluated the effects of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-10-01)
More Articles from Cancer Weekly
- Bladder Cancer
Each recurrence is sooner than the last, study shows - Breast Cancer
New imaging technology can sense tanks, as well as cancer - Cancer Therapy
Laboratory study explains clinical promise of antiangiogenesis cancer drug - Cervical Cancer
Down-regulation of cell signaling in HPV-infected cervical cells promotes malignancy - Prostate Cancer
Study of low-fat, high-fiber diet finds no effect on PSA levels in men over a 4-year period - Bladder Cancer
Antisense technology may help reverse cisplatin-resistance - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
